Status:
COMPLETED
Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation
Lead Sponsor:
Florence Nightingale Hospital, Istanbul
Conditions:
Aortic Regurgitation
Eligibility:
All Genders
18-75 years
Brief Summary
Velocity Vector Imaging may provide reliable and detailed information on left ventricular segmental function in asymptomatic patients with moderate-to severe AR. This may help to identify subclinical ...
Detailed Description
Chronic aortic regurgitation (AR) is a progressive process which causes both left ventricular volume and pressure overload. While the volume overload is associated with the degree of the aortic regurg...
Eligibility Criteria
Inclusion
- Moderate-to-severe aortic regurgitation identified by Standard echocardiography.
- Chronic isolated aortic regurgitation
- Being asymptomatic ( Class 1 according to NYHA)
- Sinusal rhythm
Exclusion
- Ejection fraction \< 50%
- Mitral valve disease accompanied to aortic regurgitation (patients with over mild degree of mitral regurgitation and stenosis
- Aortic stenosis
- Previous myocardial infarction, or the patients with \>50% coronary occlusion in any of the coronary arteries.
- Cardiomyopathies
- AV conduction disorders
- Chronic renal or hepatic insufficiency
- Malignities
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00624884
Start Date
March 1 2008
End Date
May 1 2008
Last Update
June 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology
Istanbul, Sisli, Turkey (Türkiye), 34381